Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

NCT: NCT07009236 · RECRUITING

NCT IDNCT07009236
StatusRECRUITING
Start Date2025-09-29
Completion2028-07
SponsoriSTAR Medical (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, international, cohort expansion study. Part 1 will be conducted in subjects with open angle glaucoma to identify the best insertion tool for MINIject S+. In Part 1, three different investigational insertion tools will be used to place MINIject implants in this first-in man study. Each arm represents a different version of the insertion tool. Subject and independent central reader will be blinded to the insertion tool used to implant MINIject S+. Part 2 will be an expansion phase where the selected insertion tool will be assessed in a larger population of subjects with open angle glaucoma and operable cataracts undergoing combined glaucoma and cataract surgery (with IOL implantation).

Frequently Asked Questions

What is A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma?

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma is a clinical trial registered under NCT07009236. Current status: RECRUITING.

What is the status of NCT07009236?

The current status of NCT07009236 (A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma) is: RECRUITING.

When did A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma start?

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma started on 2025-09-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.